Garonit Pharmaceutical, an India-based API maker, plans to build a $46.1 million production plant in New York to produce ...

For outsourcing and manufacturing professionals, 2024 may be remembered as the year capacity and partnerships took center ...

The deal disrupts a long-established practice of the exemption of medicines from tariffs due to their importance in public ...

Measures intended to punish elite universities are inflicting collateral damage on the nation’s two-year colleges, which ...

Duke Energy stands to benefit from rising power demand in fast-growing Southeast regions. Click here to find out why I rate ...

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

Q2 2025 Earnings Call Transcript July 31, 2025 Biogen Inc. misses on earnings expectations. Reported EPS is $ EPS, ...

Biogen raised its annual profit forecast and beat estimates for quarterly results on Thursday, as strong demand for its rare ...

Shares of the drugmaker rose nearly 8% in premarket trading. The company has focused on deals, cost-cutting measures and ...

Experts don't back specific tests, but provide guidelines on how doctors in specialty care settings can use them to diagnose ...

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

Biogen Inc. (NASDAQ: BIIB) ranks among the stocks to benefit from an onshoring boom. On July 21, Biogen Inc. (NASDAQ:BIIB) declared that it would invest $2 billion to its existing North Carolina ...